Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant

• Main Authors: Stéphanie Baillif (Author), Pascal Staccini (Author), Michel Weber (Author), Marie-Noëlle Delyfer (Author), Yannick Le Mer (Author), Vincent Gualino (Author), Laurence Collot (Author), Pierre-Yves Merite (Author), Catherine Creuzot-Garcher (Author), Laurent Kodjikian (Author), Pascale Massin (Author)
• Format: Bog
• Udgivet: MDPI AG, 2022-11-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

To assess anatomical and functional outcomes after switching from dexamethasone implant (DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a multicentric retrospective observational study was conducted. Seventy-five eyes (73.5%) were switched 1-8 weeks after their la...